Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mati Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Mati Therapeutics

Mati Therapeutics

Seed

Mati Therapeutics: Innovating non-invasive, sustained drug delivery for ocular diseases.

HQ
Austin, TX, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Mati Therapeutics, headquartered in Austin, Texas, is focused on developing a non-invasive sustained drug delivery platform to treat ocular diseases, particularly glaucoma. The company's mission is to improve the quality of life for individuals with vision impairment by providing innovative solutions that address preventable or correctable causes of blindness and vision loss. Their market focus includes patients suffering from glaucoma and other ocular conditions that require consistent and effective treatment.

Mati Therapeutics has made significant strides in the field of ophthalmology by advancing their sustained drug delivery technology. This innovation aims to reduce the frequency of treatments and improve patient compliance, ultimately leading to better health outcomes. The company’s impact is underscored by its commitment to addressing the global need for effective ocular therapies, contributing to the overall well-being of individuals with vision impairments.

Mati Therapeutics - Similar Companies

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

TherOptix logo

TherOptix

Imagen Biotech logo

Imagen Biotech

Vitranu logo

Vitranu

vitranu.com

TearClear logo

TearClear

tearclear.com

Perfuse Therapeutics logo

Perfuse Therapeutics

EyeCyte logo

EyeCyte

eyecyte.com

MediPrint Ophthalmics logo

MediPrint Ophthalmics

Spyglass Pharma logo

Spyglass Pharma

spyglasspharma.com

LumiThera logo

LumiThera

lumithera.com

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Amorphex Therapeutics logo

Amorphex Therapeutics

amorphexusa.com

Ocumension Therapeutics logo

Ocumension Therapeutics

Mahzi Therapeutics logo

Mahzi Therapeutics

mahzi.com

OcuTerra Therapeutics logo

OcuTerra Therapeutics

ocuterratx.com

Mati Therapeutics - Quick Facts

Who are Mati Therapeutics' competitors?

Companies similar to Mati Therapeutics include Ocular Therapeutix, TherOptix, Imagen Biotech and Vitranu.

When was Mati Therapeutics founded?

Mati Therapeutics was founded in 2012.

Where is Mati Therapeutics' headquarters located?

Mati Therapeutics' headquarters is located in Austin, TX, US.

When was Mati Therapeutics' last funding round?

Mati Therapeutics' most recent funding round was for $165k (USD) in May 2019.

How much has Mati Therapeutics raised to-date?

As of May 11, 2019, Mati Therapeutics has raised a total of $1.6M (USD).

How many employees does Mati Therapeutics have?

Mati Therapeutics has 30 employees as of Feb 5, 2024.

Mati Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified